Project Grant R21CA318548
Award Date 7/6/26
Completion Date 6/30/28
Dollars Obligated $427K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90032, USA
Similar Awards
- Federal Grant Award Summary The Medical University of South Carolina received a $586,018 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded July 10, 2026, with a completion date of May 31, 2031. This fully-powered three-arm clinical trial will develop and test augmented-dose nicotine replacement therapy (NRT) interventions for individuals who use both combustible cigarettes and e-cigarettes and seek to quit both...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pennsylvania a Project Grant of $663,554 under the Cancer Cause and Prevention Research program (CFDA 93.393) on August 18, 2025, with an ultimate completion date of July 31, 2030. This research project, titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit," will develop and test harm reduction product sampling as a pragmatic...
- Federal Grant Award Summary The National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded the University of Alabama a Project Grant of $2,524,071 on September 23, 2025, for research investigating the neurocomputational mechanisms underlying self-regulation and reinforcement learning in smoking cessation decisions. The four-year project, with completion scheduled for August 31, 2029, will employ computational model-based multimodal neuroimaging...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded the University of Pittsburgh a $2.2 million Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) on August 7, 2025, with a completion date of July 31, 2029. This basic experimental study with humans addresses smoking cessation and craving by investigating dyadic processes between romantic partners and smoking friends. The research integrates theoretical and methodological approaches from...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $694,182 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded June 1, 2026, with completion targeted for May 31, 2031. This five-year prospective cohort study will enroll 300 children ages 1-10 years across three exposure groups—exclusive electronic cigarette (EC) users, exclusive combustible cigarette (CC) smokers, and no...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded $621,549 to the Regents of the University of Minnesota under the Cancer Cause and Prevention Research program (CFDA 93.393) for a five-year project beginning June 1, 2026, and concluding May 31, 2031. The research will evaluate the acceptability and substitutability of nicotine pouches—a non-combustible tobacco product category—as alternatives to menthol and non-menthol combustible cigarettes. This study addresses...
- Grant Award Summary Duke University received a $906,306 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) awarded September 11, 2025, with completion targeted for August 31, 2028. The award funds development and testing of a telehealth-delivered, cue-based treatment intervention designed to promote smoking cessation among people who smoke lightly (PSLI), defined as those smoking 10 cigarettes per day or fewer. Building...
- Federal Project Grant Award Summary Chapman University received a $649,603 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), effective June 15, 2026, with completion anticipated by May 31, 2031. The TRAQ-TO-QUIT project delivers a comprehensive, multilevel smoking cessation intervention specifically designed for low-income communities by integrating three evidence-based approaches: brief pediatrician advice and...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Virginia Polytechnic Institute & State University a $395,248 Project Grant effective August 11, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct proof-of-concept and feasibility testing of episodic future thinking (EFT) interventions for smoking cessation. This two-year project, concluding July 31, 2027, will develop and evaluate both generalized EFT and cancer-specific EFT approaches...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded $467,581 to The Research Foundation for the State University of New York under the Cancer Cause and Prevention Research program (CFDA 93.393) for a two-year project grant (July 1, 2026 – June 30, 2028). The grant funds a mixed-methods research study examining the mechanisms of substance use (SU) behaviors among young adult (YA) cancer survivors aged 18–39 years. Using an exploratory sequential mixed-methods design with...